Bailard, Inc. Maravai Lifesciences Holdings, Inc. Transaction History

Bailard, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	SELL	$20.6 - $30.37 $119,892 - $176,753	-5,820 Reduced 8.53%	62,375 $1.59 Million
Q2 2022 Jul 27, 2022	BUY	$26.05 - $37.48 $53,663 - $77,208	2,060 Added 3.11%	68,195 $1.94 Million
Q1 2022 Apr 25, 2022	SELL	$24.46 - $40.92 $220 - $368	-9 Reduced 0.01%	66,135 $2.33 Million
Q4 2021 Feb 10, 2022	BUY	$35.0 - $45.94 $35,140 - $46,123	1,004 Added 1.54%	66,144 $2.77 Million
Q2 2021 Aug 13, 2021	SELL	$32.46 - $45.0 $253,123 - $350,910	-7,798 Reduced 10.69%	65,140 $2.72 Million
Q1 2021 May 13, 2021	BUY	$25.8 - $38.49 $1.88 Million - $2.81 Million	72,938 New	72,938 $2.6 Million

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $779M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.